State MD
Clinical Trials in Maryland
Recruiting clinical trials with at least one study location in Maryland. Data updated daily from ClinicalTrials.gov.
Top Conditions in Maryland
NCT05880108 N/A
Recruiting
Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilita...
Condition
Post-COVID Conditions
Enrollment
150 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT06538480 Phase 4
Recruiting
Zopa Retreatment and Vector Shedding in Adults With RRP
Condition
Recurrent Respiratory Papillomatosis
Enrollment
30 pts
Location
United States
Sponsor
Precigen, Inc
NCT05627960 Phase 1
Recruiting
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced ...
Condition
Triple Negative Breast Cancer
Enrollment
77 pts
Location
United States
Sponsor
A&G Pharmaceutical Inc.
NCT06769126 Phase 2
Recruiting
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extens...
Condition
Extensive Stage Lung Small Cell Carcinoma
Enrollment
900 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT04569591 N/A
Recruiting
DDAVP for Pituitary Adenoma
Condition
Cushing's Disease
Enrollment
22 pts
Location
United States
Sponsor
National Institute of Neurolog
NCT01568658 N/A
Recruiting
Genetic and Physical Study of Childhood Nerve and Muscle Disorders
Condition
Muscular Dystrophies
Enrollment
9,300 pts
Location
United States
Sponsor
National Institute of Neurolog
NCT03223610 Phase 1, Phase 2
Recruiting
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapse...
Condition
Lymphoma
Enrollment
155 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
NCT05327023 Phase 1, Phase 2
Recruiting
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation fo...
Condition
Hematologic Neoplasms
Enrollment
430 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07074886 Phase 2
Recruiting
A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocreli...
Condition
Multiple Sclerosis
Enrollment
182 pts
Location
United States, Argentina, Brazil
Sponsor
Hoffmann-La Roche
NCT06606990 Phase 1
Recruiting
Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With ...
Condition
Metastatic Malignant Solid Neoplasm
Enrollment
40 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05563220 Phase 1, Phase 2
Recruiting
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Vari...
Condition
Breast Cancer
Enrollment
435 pts
Location
United States, Argentina, Australia
Sponsor
Stemline Therapeutics, Inc.
NCT01964859 Phase 2
Recruiting
Feasibility Study for Fibroblast Autologous Skin Grafts
Condition
Wounds and Injuries
Enrollment
80 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05539196 N/A
Recruiting
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral ...
Condition
Movement Disorders
Enrollment
60 pts
Location
United States, Japan
Sponsor
InSightec
NCT07224074 Phase 1
Recruiting
Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEE...
Condition
Healthy Participants
Enrollment
20 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06948110 N/A
Recruiting
Deciphering the Genetic Architecture of Autoimmune Diseases
Condition
Autoimmune Diseases
Enrollment
300 pts
Location
United States, Peru
Sponsor
National Human Genome Research
NCT06912724 N/A
Recruiting
Pediatric Neuroimaging
Condition
Neurogimaging
Enrollment
80 pts
Location
United States
Sponsor
National Institute on Aging (N
NCT06275373 N/A
Recruiting
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
Condition
Thyroid Eye Disease
Enrollment
100 pts
Location
United States
Sponsor
Walter Reed National Military
NCT03206060 Phase 2
Recruiting
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paragangl...
Condition
Pheochromocytoma
Enrollment
130 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT02146170 N/A
Recruiting
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung ...
Condition
Non-Small Cell Lung Cancer
Enrollment
2,000 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06212583 Phase 2
Recruiting
High-Risk Metachronous Oligometastatic Prostate Cancer Trial
Condition
Prostate Cancer
Enrollment
88 pts
Location
United States
Sponsor
University of Maryland, Baltim
NCT06677060 Phase 3
Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdro...
Condition
Heart Failure
Enrollment
11,300 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT06491615 N/A
Recruiting
National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trad...
Condition
Inherited Ophthalmic Diseases
Enrollment
1,000 pts
Location
United States
Sponsor
National Eye Institute (NEI)
NCT05033990 N/A
Recruiting
SPIROMICS Study of Early COPD Progression (SOURCE)
Condition
COPD, Early-Onset
Enrollment
1,000 pts
Location
United States
Sponsor
University of Massachusetts, W
NCT00404560 N/A
Recruiting
Detection and Characterization of Infections and Infection Susceptibility
Condition
Immune Deficiencies
Enrollment
2,000 pts
Location
United States
Sponsor
National Institute of Allergy